carbapenems has been researched along with ambroxol in 1 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (ambroxol) | Trials (ambroxol) | Recent Studies (post-2010) (ambroxol) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 714 | 130 | 225 |
Protein | Taxonomy | carbapenems (IC50) | ambroxol (IC50) |
---|---|---|---|
Lysosomal acid glucosylceramidase | Homo sapiens (human) | 4.1 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.5574 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.391 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, X; Lu, C; Sun, S; Wang, D; Wang, Y | 1 |
1 other study(ies) available for carbapenems and ambroxol
Article | Year |
---|---|
In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ambroxol; Amlodipine; Anti-Bacterial Agents; Carbapenems; Cefoperazone; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2020 |